FDA Warns Four Facilities for Not Paying GDUFA Fees

Drug Industry Daily
A A
The FDA has warned four generic drug manufacturing facilities that they haven’t paid their GDUFA fees for the last two fiscal years, meaning all of their products are automatically misbranded.

To View This Article:

Login

Subscribe To Drug Industry Daily